Journal article

Hepcidin is suppressed by erythropoiesis in hemoglobin e β-thalassemia and β-thalassemia trait

E Jones, SR Pasricha, A Allen, P Evans, CA Fisher, K Wray, A Premawardhena, D Bandara, A Perera, C Webster, P Sturges, NF Olivieri, T St Pierre, AE Armitage, JB Porter, DJ Weatherall, H Drakesmith

Blood | ELSEVIER | Published : 2015

Abstract

Hemoglobin E (HbE) β-thalassemia is the most common severe thalassemia syndrome across Asia, and millions of people are carriers.Clinical heterogeneity in HbE β-thalassemia is incompletely explained by genotype, and the interaction of phenotypic variation with hepcidin is unknown. The effect of thalassemia carriage on hepcidin is also unknown, but it could be relevant for iron supplementation programs aimed at combating anemia. In 62 of 69 Sri Lankan patients with HbE β-thalassemia with moderate or severe phenotype, hepcidin was suppressed, and overall hepcidin inversely correlated with iron accumulation. On segregating by phenotype, there were no differences in hepcidin, erythropoiesis, or ..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Medical Research Council


Funding Acknowledgements

This work was supported by grants from the Wellcome Trust and Medical Research Council UK, the US March of Dimes, the Anthony Cerami and Ann Dunne Foundation for World Health, and the National Institute for Health Research Biomedical Research Centre Oxford. S.-R.P. is supported by fellowships from the National Health and Medical Research Council Australia, the Haematology Society of Australia and New Zealand, and the Bill and Melinda Gates Foundation.